The FDA has granted an in-person Type C meeting during the first quarter of 2026 New independent analyses across large observational ALS cohorts ...
Objective: To understand patient portal engagement stratified by patient characteristics among adults 50 years and older with at least 1 common chronic medical condition using electronic health ...
A multi-stakeholder group focused on strengthening dengue prevention and control policies in Asia[1] recently highlighted the ...
KELOWNA, BC / / December 30, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a ...
Dr. Raza Bokhari, Executive Chairman & CEO of Medicus will deliver a company presentation as Medicus enters 2026 with multiple Phase 2 Catalysts across clinical, regulatory, and pipeline expansion ...
From 2020 to 2023, 1,754 decedents had coal workers' pneumoconiosis (CWP) listed on their death certificates, according to ...
KELOWNA, BC / ACCESS Newswire / December 30, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, provides the follo ...
Meeting with leaders of Exxon Mobil, Chevron and other oil companies, the president said he wanted the industry to invest ...
News-Medical.Net on MSN
Small shifts in blood sodium may influence human brain excitability
This exploratory study in healthy young adults found that plasma sodium levels within the normal clinical range are ...
Liquidia Corporation remains a Buy for risk-tolerant biotech investors, supported by strong Yutrepia launch metrics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback